[Ranibizumab--effective, but expensive in macular degeneration].
Frennesson
Christina
C
Ogonkliniken, Universitetssjukhuset i Linköping. Christina.Frennesson@lio.se
D000368:Aged; D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018450:Disease Progression; D016527:Drug Costs; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D000069579:Ranibizumab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab